1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits for the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL THERANOSTICS MARKET BY DISEASE TYPE
5.1. Introduction
5.2. Oncology
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.2.3. Breast Cancer
5.2.4. Colorectal Cancer
5.2.5. Lung Cancer
5.2.6. Cervical Cancer
5.2.7. Others
5.3. Cardiovascular Diseases
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Neurological Disorders
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Immunological Disorders
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
5.6. Others
5.6.1. Market Trends and Opportunities
5.6.2. Growth Prospects
6. GLOBAL THERANOSTICS MARKET BY TECHNOLOGY
6.1. Introduction
6.2. Polymerase Chain Reaction (PCR)
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Immunohistochemistry (IHC)
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.4. In Situ Hybridization (ISH)
6.4.1. Market Trends and Opportunities
6.4.2. Growth Prospects
6.5. Sequencing
6.5.1. Market Trends and Opportunities
6.5.2. Growth Prospects
6.6. Others
6.6.1. Market Trends and Opportunities
6.6.2. Growth Prospects
7. GLOBAL THERANOSTICS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Diagnostic Laboratories
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Others
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
8. GLOBAL THERANOSTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Disease Type
8.2.2. By Technology
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Trends and Opportunities
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Trends and Opportunities
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Trends and Opportunities
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Disease Type
8.3.2. By Technology
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Trends and Opportunities
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Trends and Opportunities
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Trends and Opportunities
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Disease Type
8.4.2. By Technology
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.1.1. Market Trends and Opportunities
8.4.4.1.2. Growth Prospects
8.4.4.2. Germany
8.4.4.2.1. Market Trends and Opportunities
8.4.4.2.2. Growth Prospects
8.4.4.3. France
8.4.4.3.1. Market Trends and Opportunities
8.4.4.3.2. Growth Prospects
8.4.4.4. Italy
8.4.4.4.1. Market Trends and Opportunities
8.4.4.4.2. Growth Prospects
8.4.4.5. Spain
8.4.4.5.1. Market Trends and Opportunities
8.4.4.5.2. Growth Prospects
8.4.4.6. Others
8.4.4.6.1. Market Trends and Opportunities
8.4.4.6.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Disease Type
8.5.2. By Technology
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Trends and Opportunities
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Trends and Opportunities
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Trends and Opportunities
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Disease Type
8.6.2. By Technology
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.1.1. Market Trends and Opportunities
8.6.4.1.2. Growth Prospects
8.6.4.2. China
8.6.4.2.1. Market Trends and Opportunities
8.6.4.2.2. Growth Prospects
8.6.4.3. India
8.6.4.3.1. Market Trends and Opportunities
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Trends and Opportunities
8.6.4.4.2. Growth Prospects
8.6.4.5. Taiwan
8.6.4.5.1. Market Trends and Opportunities
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Trends and Opportunities
8.6.4.6.2. Growth Prospects
8.6.4.7. Indonesia
8.6.4.7.1. Market Trends and Opportunities
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Trends and Opportunities
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.2. Beckman Coulter, Inc.
10.3. Hoffmann-La Roche Ltd
10.4. Focus Diagnostics
10.5. Illumina, Inc.
10.6. Agilent Technologies, Inc.
10.7. QIAGEN
10.8. Abbott Laboratories
10.9. Foundation Medicine, Inc.